Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1583-1590

  Hein, Travis W ^a   Rosa Jr, Robert H ^a   Yuan, Zhaoxu ^a   Roberts, Elizabeth ^a   Kuo, Lih ^a,b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BRADYKININ; ENDOTHELIN 1; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RHO KINASE; ENZYME INHIBITOR; VASODILATOR AGENT;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RETINA ARTERY; RETINA BLOOD FLOW; SMOOTH MUSCLE TONE; TISSUE SECTION; VASOMOTOR REFLEX; ADRENERGIC SYSTEM; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADULT; AGED; ANIMALS; ARTERIOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RETINAL ARTERY; RHO-ASSOCIATED KINASES; SWINE; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 77949908421     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4391     Document Type: Article

References (59)

1. Braunagel SC, Xiao JG, Chiou GC. The potential role of adenosine in regulating blood flow in the eye. J Ocul Pharmacol. 1988;4:61-73.
2. Gidday JM, Park TS. Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci. 1993;34: 2713-2719.
3. ATP channels mediate adenosine-induced hyperemia in retina. Invest Ophthalmol Vis Sci. 1996;37:2624-2633.
4. Campochiaro PA, Sen HA. Adenosine and its agonists cause retinal vasodilation and hemorrhages: implications for ischemic retinopathies. Arch Ophthalmol. 1989;107:412-416.
5. Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp Eye Res. 1996;63:19-26.
6. Feldstein C, Romero C. Role of endothelins in hypertension. Am J Ther. 2007;14:147-153.
7. Ihling C, Bohrmann B, Schaefer HE, Technau-Ihling K, Loeffler BM. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis. Curr Vasc Pharmacol. 2004;2:249-258.
8. Pemp B, Garhofer G, Weigert G, et al. Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci. 2009;50:4029-4032.
9. Bek T, Hajari J, Jeppesen P. Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. Graefes Arch Clin Exp Ophthalmol. 2008;246: 763-769.
10. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulindependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37:886-897.
11. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol. 2004;88:887-891.
12. Mandecka A, Dawczynski J, Blum M, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care. 2007;30:3048-3052.
13. Michelson G, Warntges S, Harazny J, Oehmer S, Delles C, Schmieder RE. Effect of NOS inhibition on retinal arterial and capillary circulation in early arterial hypertension. Retina. 2006; 26:437-444.
14. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke. 2004;35:1289-1293.
15. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium. 2006;13:423-429.
16. Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res. 2007;26:205-238.
17. Agapitov AV, Haynes WG. Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2002;3:1-15.
18. Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ, Wang MC. Role of endothelin in diabetic retinopathy. Curr Vasc Pharmacol. 2003; 1:243-250.
19. Miao L, Dai Y, Zhang J. Mechanism of RhoA/Rho kinase activation in endothelin-1-induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol. 2002;283:H983-H989.
20. Batchelor TJ, Sadaba JR, Ishola A, Pacaud P, Munsch CM, Beech DJ. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol. 2001;132:302-308.
21. ATP channels in retinal arteriolar dilation in response to adenosine. Invest Ophthalmol Vis Sci. 2005;46:2113-2119.
22. Kulkarni P, Joshua IG, Roberts AM, Barnes G. A novel method to assess reactivities of retinal microcirculation. Microvasc Res. 1994; 48:39-49.
23. Nagaoka T, Takahashi A, Sato E, et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol. 2006;124:665-670.
24. Kuo L, Davis MJ, Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol. 1990; 259:H1063-H1070.
25. Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium-dependent and-independent vascular responses in the coronary microcirculation. Circulation. 1995;92:518-525.
26. Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci. 1985;26:1124-1132.
27. Hein TW, Xu W, Kuo L. Dilation of retinal arterioles in response to lactate: role of nitric oxide, guanylyl cyclase, and ATP-sensitive potassium channels. Invest Ophthalmol Vis Sci. 2006;47:693-699.
28. 2+ release, and RhoA activation. J Thorac Cardiovasc Surg. 2008;135:131-138.
29. Gardiner TA, Archer DB, Curtis TM, Stitt AW. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation. 2007;14:25-38.
30. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res. 2008;27:284-330.
31. Polak K, Dorner G, Kiss B, et al. Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol. 2000;84:1285-1290.
32. Dorner GT, Garhofer G, Kiss B, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003; 285:H631-H636.
33. Garhofer G, Zawinka C, Resch H, Huemer KH, Dorner GT, Schmetterer L. Diffuse luminance flicker increases blood flow in major retinal arteries and veins. Vision Res. 2004;44:833-838.
34. Smiesko V, Lang DJ, Johnson PC. Dilator response of rat mesenteric arcading arterioles to increased blood flow velocity. Am J Physiol. 1989;257:H1958-H1965.
35. Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res. 1994;74:416-421.
36. Davis MJ, Hill M, Kuo L. Local regulation of blood flow. In: Tuma RF, Duran WN, Ley K, eds. Handbook of Physiology: The Cardiovascular System: Microcirculation. Bethesda, MD: The American Physiological Society and Elsevier; 2008:159-284.
37. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
38. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435-H1440.
39. Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A. The effect of nitric oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci. 2002;43:3037-3044.
40. Yanagisawa M, Kurihara H, Kimura S, et al. A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332: 411-415.
41. Yu J, Davenport A. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol. 1995;114:551-557.
42. Maguire JJ, Johnson CM, Mockridge JW, Davenport AP. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol. 1997;122:1647-1654.
43. Ripodas A, de Juan J, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retinal and optic nerve from human and porcine eye: evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137-143.
44. Hein TW, Ren Y, Yuan Z, et al. Functional and molecular characterization of the endothelin system in retinal arterioles. Invest Ophthalmol Vis Sci. 2009;50:3329-3336.
45. Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol. 1998;82:498-503.
46. Haufschild T, Prunte C, Messerli J, Flammer J. Increased endothelin-1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monatsbl Augenheilkd. 2004;221:357-359.
47. Emre M, Orgül S, Haufschild T, Shaw S, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89:60-63.
48. Oku H, Kida T, Sugiyama T, Hamada J, Sato B, Ikeda T. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina. 2001;21:647-651.
49. Roldan-Pallares M, Rollin R, Mediero A, et al. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Mol Vis. 2005;11:461-471.
50. Resch H, Karl K, Weigert G, et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009;50:358-363.
51. Yu DY, Su EN, Cringle SJ, Alder VA, Yu PK, Desantis L. Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles. Exp Eye Res. 1998;67:73-81.
52. Grantham JA, Schirger JA, Williamson EE, et al. Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis. J Cardiovasc Pharmacol. 1998;31:S22-S26.
53. Nyborg N, Prieto D, Benedito S, Nielsen P. Endothelin-1-induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. Invest Ophthalmol Vis Sci. 1991;32:27-31.
54. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rhokinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177-185.
55. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol. 2006;290:C661-C668.
56. Masumoto A, Hirooka Y, Hironaga K, et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Am J Cardiol. 2001;88: 1291-1294.
57. Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rhoassociated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009;119:131-138.
58. Nagaoka T, Hein TW, Yoshida A, Kuo L. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonaterho kinase pathways. Invest Ophthalmol Vis Sci. 2007;48:825-832.
59. Haefliger IO, Flammer J, Beny JL, Luscher TF. Endothelium-dependent vasoactive modulation in the ophthalmic circulation. Prog Retin Eye Res. 2001;20:209-225.